JP2023515424A5 - - Google Patents
Info
- Publication number
- JP2023515424A5 JP2023515424A5 JP2022549282A JP2022549282A JP2023515424A5 JP 2023515424 A5 JP2023515424 A5 JP 2023515424A5 JP 2022549282 A JP2022549282 A JP 2022549282A JP 2022549282 A JP2022549282 A JP 2022549282A JP 2023515424 A5 JP2023515424 A5 JP 2023515424A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- composition according
- seq
- use according
- small molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062979442P | 2020-02-21 | 2020-02-21 | |
| US62/979,442 | 2020-02-21 | ||
| PCT/CA2021/050176 WO2021163796A1 (en) | 2020-02-21 | 2021-02-18 | Methods and compositions for the inhibition of hepatitis b and hepatitis d virus infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023515424A JP2023515424A (ja) | 2023-04-13 |
| JP2023515424A5 true JP2023515424A5 (enExample) | 2024-02-29 |
Family
ID=77390241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549282A Pending JP2023515424A (ja) | 2020-02-21 | 2021-02-18 | Ｂ型肝炎及びｄ型肝炎ウイルス感染を阻害するための方法及び組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230056788A1 (enExample) |
| EP (1) | EP4106768A1 (enExample) |
| JP (1) | JP2023515424A (enExample) |
| KR (1) | KR20220145862A (enExample) |
| CN (1) | CN115087451A (enExample) |
| AU (1) | AU2021224509A1 (enExample) |
| BR (1) | BR112022014717A2 (enExample) |
| CA (1) | CA3164677A1 (enExample) |
| IL (1) | IL295593A (enExample) |
| MX (1) | MX2022010346A (enExample) |
| WO (1) | WO2021163796A1 (enExample) |
| ZA (1) | ZA202208412B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250223325A1 (en) * | 2022-08-08 | 2025-07-10 | Viron, Inc. | Functional porosome manipulation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305813A3 (en) * | 2002-11-14 | 2012-03-28 | Dharmacon, Inc. | Fuctional and hyperfunctional sirna |
| CA2566286A1 (en) * | 2004-05-11 | 2005-12-08 | Rnai Co., Ltd. | Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same |
| WO2019112489A1 (en) * | 2017-12-05 | 2019-06-13 | Limited Liability Company "Gero" | Methods and agents for treatment of aging and aging related conditions and diseases |
-
2021
- 2021-02-18 WO PCT/CA2021/050176 patent/WO2021163796A1/en not_active Ceased
- 2021-02-18 KR KR1020227032637A patent/KR20220145862A/ko not_active Withdrawn
- 2021-02-18 AU AU2021224509A patent/AU2021224509A1/en active Pending
- 2021-02-18 US US17/792,746 patent/US20230056788A1/en active Pending
- 2021-02-18 MX MX2022010346A patent/MX2022010346A/es unknown
- 2021-02-18 CN CN202180013791.XA patent/CN115087451A/zh active Pending
- 2021-02-18 CA CA3164677A patent/CA3164677A1/en active Pending
- 2021-02-18 IL IL295593A patent/IL295593A/en unknown
- 2021-02-18 BR BR112022014717A patent/BR112022014717A2/pt unknown
- 2021-02-18 JP JP2022549282A patent/JP2023515424A/ja active Pending
- 2021-02-18 EP EP21757260.1A patent/EP4106768A1/en not_active Withdrawn
-
2022
- 2022-07-27 ZA ZA2022/08412A patent/ZA202208412B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20260069625A1 (en) | Organic compositions to treat kras-related diseases | |
| JP7059242B2 (ja) | 筋強直性ジストロフィープロテインキナーゼ（ｄｍｐｋ）の発現を調節するための化合物及び方法 | |
| AU2013296321B2 (en) | Modified RNAi agents | |
| JP2009536827A5 (enExample) | ||
| JP2026077722A (ja) | Ｄｕｘ４阻害剤およびその使用方法 | |
| CN102712926A (zh) | 用于抑制基因表达的组合物及其用途 | |
| CA2921457A1 (en) | Heterochromatin forming non-coding rnas | |
| JP2010532163A5 (enExample) | ||
| JP2023539341A5 (enExample) | ||
| JP2005525802A (ja) | 血管治療 | |
| JP2023506546A (ja) | Ｂ型肝炎ウイルス感染症を処置するためのｓｅｐｔ９阻害剤の使用 | |
| JP2024528252A (ja) | 核酸医薬の徐放性能の強化方法 | |
| JP2026002846A (ja) | Ａｎｇｐｔｌ２アンチセンスオリゴヌクレオチドおよびその使用 | |
| KR101783444B1 (ko) | miR-33-5p 를 이용한 뇌신경세포 보호 물질 스크리닝 방법 | |
| JP2023506954A (ja) | Ｂ型肝炎ウイルス感染を処置するためのｓａｒａｆ阻害剤の使用 | |
| JP2025531483A (ja) | 神経炎症疾患の治療のための組成物及び方法 | |
| WO2023168202A2 (en) | Certain dux4 inhibitors and methods of use thereof | |
| JP7208911B2 (ja) | 核酸分子発現の調節 | |
| EP2175023A1 (en) | Anti-tumor activity of small double-stranded oligodeoxynucleotides targeting telomerase RNA | |
| JP2023515424A (ja) | Ｂ型肝炎及びｄ型肝炎ウイルス感染を阻害するための方法及び組成物 | |
| JP2023506547A (ja) | Ｂ型肝炎ウイルス感染を処置するためのｃｏｐｓ３阻害剤の使用 | |
| EP2689013A1 (en) | Compositions for inhibiting gene expression and uses thereof | |
| JP2025517965A5 (enExample) | ||
| JP2025531484A (ja) | 神経炎症性疾患の処置のための組成物及び方法 | |
| WO2025165814A8 (en) | Compositions and methods for regulating cardiac angiogenesis post ischemia |